# MacKenzie Realty Capital, Inc.: financial statements, quarterly

MKZR · Nasdaq · CIK 1550913 · [Real estate](/sectors/real-estate.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/mkzr.md) · [Financials](/companies/mkzr/financials.md) · [Filings](/companies/mkzr/filings.md) · [Insiders](/companies/mkzr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mkzr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,560](/filings/0001140361-24-046881.md) | [3,577](/filings/0001140361-25-004609.md) | [4,079](/filings/0001140361-25-019315.md) | [4,520 d](/filings/0001140361-25-036540.md) | [4,952](/filings/0001140361-25-042280.md) | [8,030](/filings/0001140361-26-005766.md) | [4,274](/filings/0001140361-26-021627.md) | [4,804 d](/filings/0001140361-26-037858.md) | [4,539](/filings/0001140361-25-042280.md) | [4,594](/filings/0001140361-26-005766.md) | [5,442](/filings/0001140361-26-021627.md) | [5,433 d](/filings/0001140361-26-037858.md) |
| Operating income | $k | [(2,257)](/filings/0001140361-24-046881.md) | [(2,358)](/filings/0001140361-25-004609.md) | [(2,678)](/filings/0001140361-25-019315.md) | [(2,625) d](/filings/0001140361-25-036540.md) | [(7,441)](/filings/0001140361-25-042280.md) | [(4,555)](/filings/0001140361-26-005766.md) | [(5,830)](/filings/0001140361-26-021627.md) | [(5,636) d](/filings/0001140361-26-037858.md) | [(3,488)](/filings/0001140361-25-042280.md) | [(4,710)](/filings/0001140361-26-005766.md) | [(2,501)](/filings/0001140361-26-021627.md) | [(4,914) d](/filings/0001140361-26-037858.md) |
| Interest expense | $k | [1,322](/filings/0001140361-23-052952.md) | [1,453](/filings/0001140361-24-007491.md) | [1,602](/filings/0001140361-24-026184.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(4,209)](/filings/0001140361-24-046881.md) | [(1,554)](/filings/0001140361-25-004609.md) | [(2,948)](/filings/0001140361-25-019315.md) | [(2,513) d](/filings/0001140361-25-036540.md) | [(7,408)](/filings/0001140361-25-042280.md) | [(4,458)](/filings/0001140361-26-005766.md) | [(6,093)](/filings/0001140361-26-021627.md) | [(6,011) d](/filings/0001140361-26-037858.md) | [(3,047)](/filings/0001140361-25-042280.md) | [(4,475)](/filings/0001140361-26-005766.md) | [(986)](/filings/0001140361-26-021627.md) | [(5,620) d](/filings/0001140361-26-037858.md) |
| Diluted EPS | $ per share | [(0.35)](/filings/0001140361-24-046881.md) | not reported | [(0.26)](/filings/0001140361-25-019315.md) | not reported | [(6.10)](/filings/0001140361-25-042280.md) | [(3.93)](/filings/0001140361-26-005766.md) | [(4.68)](/filings/0001140361-26-021627.md) | not reported | [(2.20)](/filings/0001140361-25-042280.md) | [(2.97)](/filings/0001140361-26-005766.md) | [(0.98)](/filings/0001140361-26-021627.md) | not reported |
| Basic EPS | $ per share | [(0.35)](/filings/0001140361-24-046881.md) | [(0.15)](/filings/0001140361-25-004609.md) | [(0.26)](/filings/0001140361-25-019315.md) | not reported | [(6.10)](/filings/0001140361-25-042280.md) | [(3.93)](/filings/0001140361-26-005766.md) | [(4.68)](/filings/0001140361-26-021627.md) | not reported | [(2.20)](/filings/0001140361-25-042280.md) | [(2.97)](/filings/0001140361-26-005766.md) | [(0.98)](/filings/0001140361-26-021627.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.0](/filings/0001140361-24-046881.md) | [12.2](/filings/0001140361-25-004609.md) | [15.5](/filings/0001140361-25-019315.md) | [11.9](/filings/0001140361-25-036540.md) | [10.7](/filings/0001140361-25-042280.md) | [6.5](/filings/0001140361-26-005766.md) | [5.1](/filings/0001140361-26-021627.md) | [3.6](/filings/0001140361-26-037858.md) | [4.9](/filings/0001140361-25-042280.md) | [4.3](/filings/0001140361-26-005766.md) | [4.0](/filings/0001140361-26-021627.md) | [3.5](/filings/0001140361-26-037858.md) |
| Total assets | $m | [211](/filings/0001140361-23-052952.md) | [205](/filings/0001140361-24-007491.md) | [226](/filings/0001140361-24-026184.md) | [233](/filings/0001140361-25-036540.md) | [244](/filings/0001140361-24-046881.md) | [236](/filings/0001140361-25-004609.md) | [237](/filings/0001140361-25-019315.md) | [236](/filings/0001140361-26-037858.md) | [242](/filings/0001140361-25-042280.md) | [238](/filings/0001140361-26-005766.md) | [239](/filings/0001140361-26-021627.md) | [235](/filings/0001140361-26-037858.md) |
| Total liabilities | $m | [105](/filings/0001140361-23-052952.md) | [102](/filings/0001140361-24-007491.md) | [118](/filings/0001140361-24-026184.md) | [125](/filings/0001140361-25-036540.md) | [142](/filings/0001140361-24-046881.md) | [139](/filings/0001140361-25-004609.md) | [139](/filings/0001140361-25-019315.md) | [142](/filings/0001140361-26-037858.md) | [151](/filings/0001140361-25-042280.md) | [152](/filings/0001140361-26-005766.md) | [154](/filings/0001140361-26-021627.md) | [156](/filings/0001140361-26-037858.md) |
| Long-term debt | $m | not reported | [14.0](/filings/0001140361-25-036540.md) | not reported | [117](/filings/0001140361-24-042226.md) | not reported | [14.7](/filings/0001140361-25-004609.md) | not reported | [135](/filings/0001140361-25-036540.md) | [143](/filings/0001140361-25-042280.md) | [146](/filings/0001140361-26-005766.md) | [147](/filings/0001140361-26-021627.md) | [148](/filings/0001140361-26-037858.md) |
| Shareholders' equity | $m | [93.9](/filings/0001140361-23-052952.md) | [90.5](/filings/0001140361-24-007491.md) | [86.3](/filings/0001140361-24-026184.md) | [82.4](/filings/0001140361-25-036540.md) | [73.4](/filings/0001140361-24-046881.md) | [68.3](/filings/0001140361-25-004609.md) | [66.7](/filings/0001140361-25-019315.md) | [59.9](/filings/0001140361-26-037858.md) | [56.7](/filings/0001140361-25-042280.md) | [51.8](/filings/0001140361-26-005766.md) | [50.8](/filings/0001140361-26-021627.md) | [43.8](/filings/0001140361-26-037858.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [517](/filings/0001140361-24-046881.md) | [(1,103) d](/filings/0001140361-25-004609.md) | [743 d](/filings/0001140361-25-019315.md) | [(753) d](/filings/0001140361-25-036540.md) | [644](/filings/0001140361-25-042280.md) | [1,872 d](/filings/0001140361-26-005766.md) | [(2,570) d](/filings/0001140361-26-021627.md) | [(1,637) d](/filings/0001140361-26-037858.md) | [(2,020)](/filings/0001140361-25-042280.md) | [(1,569) d](/filings/0001140361-26-005766.md) | [833 d](/filings/0001140361-26-021627.md) | [(553) d](/filings/0001140361-26-037858.md) |
| Dividends paid | $k | [1,346](/filings/0001140361-24-046881.md) | [987 d](/filings/0001140361-25-004609.md) | [1,188 d](/filings/0001140361-25-019315.md) | [1,660 d](/filings/0001140361-25-036540.md) | [1,663](/filings/0001140361-25-042280.md) | [1,679 d](/filings/0001140361-26-005766.md) | [674 d](/filings/0001140361-26-021627.md) | [787 d](/filings/0001140361-26-037858.md) | [0.0](/filings/0001140361-25-042280.md) | [0.0 d](/filings/0001140361-26-005766.md) | [0.0 d](/filings/0001140361-26-021627.md) | [0.0 d](/filings/0001140361-26-037858.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | period not labelled (2020-09-30) | Q3 FY2022 (2021-03-31) | Q1 FY2022 (2021-09-30) | Q1 FY2023 (2022-09-30) | Q1 FY2024 (2023-09-30) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.8](/filings/0001140361-21-037694.md) | [13.4](/filings/0001140361-22-019126.md) | [13.3](/filings/0001140361-22-041454.md) | [13.3](/filings/0001140361-23-052952.md) | [13.3](/filings/0001140361-24-046881.md) | [13.3](/filings/0001140361-25-019315.md) | [1.3](/filings/0001140361-25-042280.md) | [1.3](/filings/0001140361-26-005766.md) | [1.5](/filings/0001140361-26-021627.md) | [1.9](/filings/0001140361-25-042280.md) | [1.9](/filings/0001140361-26-005766.md) | [2.1](/filings/0001140361-26-021627.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 2,774,688 at 2026-09-28, from the cover of the [10-K filed 2026-09-28](/filings/0001140361-26-037858.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.